WeVote
Log In

Bill

Bill

SB 483

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

2023-2024 Regular Session Introduced by Sarah Anthony and 17 co-sponsors

Michigan establishes prescription drug affordability review act to monitor and regulate pharmaceutical pricing, aiming to improve medication access and affordability for state residents.

referred to Committee on Insurance and Financial Services
#health:pharmaceuticals #stateagencies(existing):boardsandcommissions #stateagencies(existing):insuranceandfinancialservices
0
WeVote Research Nonpartisan
Bill Summary · SB 483

Legislative bill overview

SB 483 establishes Michigan's Prescription Drug Cost and Affordability Review Act, creating a new regulatory framework to monitor and address pharmaceutical pricing practices. The bill would empower state authorities to review prescription drug costs and implement measures aimed at improving medication affordability for Michigan residents.

Why is this important

Prescription drug costs represent a significant portion of healthcare expenses for many Michigan families, and rising prices can prevent people from accessing necessary medications. This legislation attempts to address that burden by creating oversight mechanisms, potentially impacting drug pricing transparency and access across the state.

Potential points of contention

  • Industry opposition: Pharmaceutical manufacturers may argue that price regulation discourages innovation and research investment, and could affect drug availability in the state
  • Implementation costs: Creating new regulatory infrastructure requires state funding and staffing, raising questions about budget allocation and administrative efficiency
  • Federal authority overlap: Questions about whether Michigan can effectively regulate drug prices when pharmaceutical markets operate nationally and federally, potentially creating compliance complications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.